Alan Roloff

Alan Roloff, Ph.D. serves as a Principal Medical Science Liaison at Alector since May 2022, following a tenure as Sr. Medical Science Liaison at Greenwich Biosciences, where focus was on cannabinoid neurology. Previous roles include Senior Regional Medical Liaison positions in neurology at Bristol-Myers Squibb and Celgene, as well as Senior Medical Science Liaison at Biogen. Prior experience includes a Clinical Science Consultant role at Boehringer Ingelheim Pharmaceuticals and a Postdoctoral Fellowship at the University of Minnesota specializing in endocannabinoid pharmacology. Academic qualifications include a Ph.D. in Pharmacology from the University of Minnesota and a BS in Biochemistry/Molecular Biology from the University of Wisconsin-Eau Claire.